BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 6315763)

  • 21. Sporadic pancreatic vasoactive intestinal peptide-producing tumor (VIPoma) in a 47-year-old male.
    Abu-Zaid A; Azzam A; Abudan Z; Algouhi A; Almana H; Amin T
    Hematol Oncol Stem Cell Ther; 2014 Sep; 7(3):109-15. PubMed ID: 24785507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of ganglionic blockade on endogenous circulating pancreatic polypeptide, vasoactive intestinal polypeptide, substance P, neurotensin and noradrenaline in healthy controls and long-term insulin-dependent diabetic patients.
    Kastrup J; Henriksen JH; Pedersen JH; Fahrenkrug J; Schaffalitzky de Muckadell OB; Schwartz T; Parving HH; Christensen NJ
    Clin Sci (Lond); 1986 Oct; 71(4):411-9. PubMed ID: 2428557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vasoactive intestinal peptide (VIP) secreting tumour of the pancreas.
    Sandström R; Alhava EM; Poikolainen E; Puittinen J; Soimakallio S
    Ann Chir Gynaecol; 1981; 70(3):124-7. PubMed ID: 6275768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Secretin, cholecystokinin, and vasoactive intestinal polypeptide in pancreatic cholera.
    Achord JL
    Ann Intern Med; 1986 Oct; 105(4):632. PubMed ID: 3019205
    [No Abstract]   [Full Text] [Related]  

  • 25. A pancreatic-polypeptide-producing tumour associated with the WDHA syndrome.
    Lundqvist G; Krause U; Larsson LI; Grimelius L; Schaffalitzky de Muckadell OB; Fahrenkrug J; Johnson M; Chance RE
    Scand J Gastroenterol; 1978; 13(6):715-8. PubMed ID: 151327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypokalemic rhabdomyolysis without watery diarrhea: an unexpected presentation of a pancreatic neuro-endocrine tumor.
    Rossi V; Saibeni S; Sinigaglia L; Peracchi M; Parafioriti A; Vecchi M
    Am J Gastroenterol; 2006 Mar; 101(3):669-72. PubMed ID: 16464230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Watery diarrhoea and a vasoactive intestinal peptide secreting ganglioneuroma.
    Dorney SF; Kamath KR; Shulkes AA; Middleton AW
    Med J Aust; 1984 Jan; 140(2):97-9. PubMed ID: 6319979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [VIP and GIP-producing pancreatic tumour: relationship to the Verner-Morrison syndrome].
    Kunert H; Kuhn FM; Schwemmle K; Ottenjann R
    Dtsch Med Wochenschr; 1976 Jun; 101(24):920-3. PubMed ID: 179772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Organ and plasma metabolism of neurotensin in sheep.
    Shulkes A; Fletcher DR; Hardy KJ
    Am J Physiol; 1983 Nov; 245(5 Pt 1):E457-62. PubMed ID: 6638173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Long-term therapy of a metastasizing pancreatic vipoma using the somatostatin derivative octreotide].
    Flückiger A; Schlup P
    Schweiz Med Wochenschr; 1992 Aug; 122(33):1221-3. PubMed ID: 1326786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A combined glucagonoma and VIPoma syndrome. First pathologic and clinical report.
    Cavallo-Perin P; De Paoli M; Guiso G; Sapino A; Papotti M; Coda R; Pagano G
    Cancer; 1988 Dec; 62(12):2576-9. PubMed ID: 2847862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diarrhoea in vipoma patients associated with cosecretion of a second active peptide (peptide histidine isoleucine) explained by single coding gene.
    Bloom SR; Christofides ND; Delamarter J; Buell G; Kawashima E; Polak JM
    Lancet; 1983 Nov; 2(8360):1163-5. PubMed ID: 6139527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Vasoactive intestinal peptide (VIP) in the Verner-Morrison syndrome (author's transl)].
    Grenier JF; Marescaux J; Michel F; Sava G; Kachelhoffer J
    Nouv Presse Med; 1979 Apr; 8(18):1505-8. PubMed ID: 224378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of vasoactive intestinal peptide release in short-term culture of vasoactive intestinal peptide-producing tumor.
    Harty RF; Jain DK; McGuigan JE
    Gastroenterology; 1988 Feb; 94(2):513-8. PubMed ID: 2446951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma neurotensin in the conscious pig: release by individual food components and effects on exocrine pancreas secretion.
    Cuber JC; Philippe C; Abello J; Corring T; Levenez F; Chayvialle JA
    Pancreas; 1990 May; 5(3):306-13. PubMed ID: 2343043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vasoactive intestinal polypeptide (VIP) as a mediator of the watery diarrhea syndrome.
    Said SI
    World J Surg; 1979 Sep; 3(5):559-63. PubMed ID: 229653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pancreatic polypeptide-secreting islet-cell tumors. A study of three cases.
    Tomita T; Friesen SR; Kimmel JR; Doull V; Pollock HG
    Am J Pathol; 1983 Nov; 113(2):134-42. PubMed ID: 6314815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary endocrine-secreting pancreatic tumors.
    Macaron C
    Am Fam Physician; 1980 Apr; 21(4):94-8. PubMed ID: 6103668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A patient with Verner-Morrison's syndrome--a vasoactive intestinal peptide (VIP)-mediated watery diarrhoea syndrome?
    Meuwese-Arends MT; Yap SH; Van Tongeren JH
    Neth J Med; 1980; 23(2):107-10. PubMed ID: 6246463
    [No Abstract]   [Full Text] [Related]  

  • 40. [Pancreatic vipoma with bizarre characteristics].
    Bermejo F; Moreno L; Moreira V; Gisbert JP; González Palacios F; García López JL
    Gastroenterol Hepatol; 1999 Mar; 22(3):132-5. PubMed ID: 10228323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.